BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 16177987)

  • 1. A Phase I study of concurrent RMP-7 and carboplatin with radiation therapy for children with newly diagnosed brainstem gliomas.
    Packer RJ; Krailo M; Mehta M; Warren K; Allen J; Jakacki R; Villablanca JG; Chiba A; Reaman G
    Cancer; 2005 Nov; 104(9):1968-74. PubMed ID: 16177987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase 1 study of concurrent RMP-7 and carboplatin with radiotherapy for children with newly diagnosed brainstem gliomas.
    Packer RJ; Krailo M; Mehta M; Warren K; Allen J; Jakacki R; Villablanca JG; Chiba A; Reaman G
    Cancer; 2005 Sep; 104(6):1281-7. PubMed ID: 16078267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of children with diffuse intrinsic brain stem glioma with radiotherapy, vincristine and oral VP-16: a Children's Oncology Group phase II study.
    Korones DN; Fisher PG; Kretschmar C; Zhou T; Chen Z; Kepner J; Freeman C
    Pediatr Blood Cancer; 2008 Feb; 50(2):227-30. PubMed ID: 17278121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topotecan as a radiosensitizer in the treatment of children with malignant diffuse brainstem gliomas: results of a French Society of Paediatric Oncology Phase II Study.
    Bernier-Chastagner V; Grill J; Doz F; Bracard S; Gentet JC; Marie-Cardine A; Luporsi E; Margueritte G; Lejars O; Laithier V; Mechinaud F; Millot F; Kalifa C; Chastagner P
    Cancer; 2005 Dec; 104(12):2792-7. PubMed ID: 16265674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of children with newly diagnosed brain stem gliomas with intravenous recombinant beta-interferon and hyperfractionated radiation therapy: a childrens cancer group phase I/II study.
    Packer RJ; Prados M; Phillips P; Nicholson HS; Boyett JM; Goldwein J; Rorke LB; Needle MN; Sutton L; Zimmerman RA; Fitz CR; Vezina LG; Etcubanas E; Wallenberg JC; Reaman G; Wara W
    Cancer; 1996 May; 77(10):2150-6. PubMed ID: 8640684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of metronomic chemotherapy with thalidomide, carboplatin-vincristine-fluvastatin in the treatment of brain stem tumors in children.
    López-Aguilar E; Sepúlveda-Vildósola AC; Betanzos-Cabrera Y; Rocha-Moreno YG; Gascón-Lastiri G; Rivera-Márquez H; Wanzke-del-Angel V; Cerecedo-Díaz F; de la Cruz-Yañez H
    Arch Med Res; 2008 Oct; 39(7):655-62. PubMed ID: 18760193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etoposide, vincristine, and cyclosporin A with standard-dose radiation therapy in newly diagnosed diffuse intrinsic brainstem gliomas: a pediatric oncology group phase I study.
    Greenberg ML; Fisher PG; Freeman C; Korones DN; Bernstein M; Friedman H; Blaney S; Hershon L; Zhou T; Chen Z; Kretschmar C
    Pediatr Blood Cancer; 2005 Oct; 45(5):644-8. PubMed ID: 16110498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH).
    Gnekow AK; Kortmann RD; Pietsch T; Emser A
    Klin Padiatr; 2004; 216(6):331-42. PubMed ID: 15565548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [HIT-LGG: effectiveness of carboplatin-vincristine in progressive low-grade gliomas of childhood--an interim report].
    Gnekow AK; Kaatsch P; Kortmann R; Wiestler OD
    Klin Padiatr; 2000; 212(4):177-84. PubMed ID: 10994547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperfractionated radiotherapy for children with brainstem gliomas: a pilot study using 7,200 cGy.
    Packer RJ; Allen JC; Goldwein JL; Newall J; Zimmerman RA; Priest J; Tomita T; Mandelbaum DE; Cohen BH; Finlay JL
    Ann Neurol; 1990 Feb; 27(2):167-73. PubMed ID: 2317012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of high-dose chemotherapy before radiation in children with newly diagnosed high-grade astrocytoma: final analysis of Children's Cancer Group Study 9933.
    MacDonald TJ; Arenson EB; Ater J; Sposto R; Bevan HE; Bruner J; Deutsch M; Kurczynski E; Luerssen T; McGuire-Cullen P; O'Brien R; Shah N; Steinbok P; Strain J; Thomson J; Holmes E; Vezina G; Yates A; Phillips P; Packer R
    Cancer; 2005 Dec; 104(12):2862-71. PubMed ID: 16315242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of hypofractionation radiotherapy for diffuse intrinsic brainstem glioma in children: a pilot study.
    Janssens GO; Gidding CE; Van Lindert EJ; Oldenburger FR; Erasmus CE; Schouten-Meeteren AY; Kaanders JH
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):722-6. PubMed ID: 18990510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase I/II study of carboplatin combined with hyperfractionated radiotherapy for brainstem gliomas.
    Allen J; Siffert J; Donahue B; Nirenberg A; Jakacki R; Robertson P; DaRosso R; Thoron L; Rosovsky M; Pinto R
    Cancer; 1999 Sep; 86(6):1064-9. PubMed ID: 10491535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent carbogen and radiation therapy in children with high-risk brainstem gliomas.
    Aquino-Parsons C; Hukin J; Green A
    Pediatr Blood Cancer; 2008 Feb; 50(2):397-9. PubMed ID: 17009221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.
    Thorarinsdottir HK; Rood B; Kamani N; Lafond D; Perez-Albuerne E; Loechelt B; Packer RJ; MacDonald TJ
    Pediatr Blood Cancer; 2007 Mar; 48(3):278-84. PubMed ID: 16456857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer.
    Haddad R; Sonis S; Posner M; Wirth L; Costello R; Braschayko P; Allen A; Mahadevan A; Flynn J; Burke E; Li Y; Tishler RB
    Cancer; 2009 Oct; 115(19):4514-23. PubMed ID: 19634161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of diffuse intrinsic brainstem gliomas: failed approaches and future strategies.
    Frazier JL; Lee J; Thomale UW; Noggle JC; Cohen KJ; Jallo GI
    J Neurosurg Pediatr; 2009 Apr; 3(4):259-69. PubMed ID: 19338403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent radiotherapy: fotemustine combination for newly diagnosed malignant glioma patients, a phase II study.
    Beauchesne PD; Taillandier L; Bernier V; Carnin C
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):171-5. PubMed ID: 19352662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction chemotherapy with paclitaxel plus carboplatin followed by paclitaxel with concurrent radiotherapy in stage IIIB non-small-cell lung cancer (NSCLC) patients: a phase II trial.
    Pallarés C; Capdevila J; Paredes A; Farré N; Ciria JP; Membrive I; Basterrechea L; Gomez-Segura G; Barnadas A
    Lung Cancer; 2007 Nov; 58(2):238-45. PubMed ID: 17658655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.